As bad as the state of affairs are with this coy, the substantial shareholders keep on buying up. They must see some value there. Any thoughts out there?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025